Live news related to SANOFI stock (FR0000120578): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on SANOFI mainly cover M&A activity. The stock trades at €74,03 on Euronext Paris, down 1,86% at the last update. This page lists the articles published on SANOFI stock to track the share price, company announcements and any item likely to influence market perception.
Sanofi is losing ground on Tuesday in a globally stable CAC 40, thus amplifying its recent decline. The stock is under pressure from its moving averag…
In a challenging trading session for the Paris index, Sanofi displays significant progress that stands out from the prevailing trend. The stock benefi…
Sanofi would enter Cheplapharm's capital at 26.4% in exchange for the transfer of a selection of mature medicines and three industrial sites. The tran…
The European Commission has approved an extension of indication for Sanofi's meningococcal vaccine MenQuadfi, enabling its use in infants from six wee…
On July 21, Sanofi announced changes to its executive committee, effective September 1, 2026. This reorganization focuses power around business activi…
Following his appointment as Executive Vice President, Global Head of Research & Development Pharma at Sanofi, Paulo Fontoura announced his resignatio…
The French pharmaceutical company marks one of the strongest gains in the CAC 40 by mid-morning. This movement follows the U.S. regulator's approval o…
The FDA has approved the subcutaneous formulation of Sarclisa, administered via an on-body injector, for the treatment of multiple myeloma. The drug b…
The pharmaceutical company marks one of the sharpest rebounds in the CAC 40 mid-morning, after a decline phase that had driven the stock below its mov…
Sanofi announced on Tuesday positive phase 3 results for Nexviazyme in treating the early-infantile form of Pompe disease in infants. The company plan…
